Korro Bio (KRRO) Price to Sales (2019 - 2025)

Korro Bio (KRRO) has reported Price to Sales for 5 consecutive years, with 58.38 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Price to Sales fell 62.86% year-over-year to 58.38; the trailing twelve-month figure through Jun 2026 stood at 81.37 (up 335.73% YoY), and the FY2025 full-year result was 11.8, down 92.49% from the prior year.
• Price to Sales fell to 58.38 in Q4 2025 per KRRO's latest filing, from 412.91 in the prior quarter.
• Across five years, Price to Sales topped out at 412.91 in Q3 2025 and bottomed at 36.37 in Q2 2021.
• Historically, Price to Sales has averaged 125.6 across 3 years, with a median of 69.89 in 2021.
• The sharpest annual moves came in 2021 and 2025: Price to Sales retreated 8.08% in 2021, then tumbled 62.86% in 2025.
• Over 3 years, Price to Sales stood at 36.37 in 2021, then surged by 332.23% to 157.2 in 2024, then sank by 62.86% to 58.38 in 2025.
• According to Business Quant data, Price to Sales over the past three periods registered 58.38, 412.91, and 80.34 for Q4 2025, Q3 2025, and Q2 2025 respectively.